Life Sciences | How to Respond to an FDA Investigation [WEBINAR]

Michael Cremeans, Life Sciences Practice leader at Oswald hosted a webinar to discuss how to respond to an FDA investigation.  Joining him was Drew R. Barnholtz, Attorney at Law at Schneider, Smeltz, Ranney & LaFond, P.L.L.

During the presentation, the team addressed how to respond if you were faced with an investigation, whether it be a 483 observation, a warning letter, or a Consent Decree, all of which will impact how you carry on your business while under investigation.

Drew has “been there, done that” when it comes to the FDA investigation and Consent Decree process. Learn firsthand of his experience and how his company survived the ordeal.

You can watch the recorded session HERE.

Learn more about Oswald’s Life Sciences practice.